Predictive Oncology Inc (NAS:POAI)
$ 0.791 -0.0402 (-4.84%) Market Cap: 5.54 Mil Enterprise Value: 4.65 Mil PE Ratio: 0 PB Ratio: 2.82 GF Score: 51/100

Q1 2024 Predictive Oncology Inc Earnings Call Transcript

May 15, 2024 / 12:30PM GMT
Release Date Price: $1.74
Operator

Ladies and gentlemen, good morning, and thank you for standing by. Welcome to the Predictive Oncology Q1 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded, and I would now like to hand the conference over to your speaker, Mr. Glenn Garmont, Investor Relations. Mr. Garmont, please go ahead.

Glenn Garmont
LifeSci Venture Partners LP - Investor Relations

Welcome, and thank you, everyone, for dialing into the Predictive Oncology first quarter 2024 financial results call. First, you'll hear from our Chief Executive Officer and Chairman of the Board of Raymond Vennare. Then our Chief Financial Officer, Josh Blacher, will review our financials.

Certain matters discussed on this call contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make.

All statements other than statements of historical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot